Search results for “Ustekinumab” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 83 patents, we discovered top 18 key players by total patent application. Janssen Biotech, Momenta Pharmaceuticals, Inc., Dong-A Socio Holdings Co., Ltd. are dominant in this area. They take 66.27% of the total patent filing.
Janssen Biotech
Belgium
Patent: 39
Momenta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 10
Dong-A Socio Holdings Co., Ltd.
South Korea
Patent: 6
Nestec SA
Vaud, Switzerland
Patent: 6
Meiji Seika Pharma Co., Ltd.
Tokyo-to, Japan
Patent: 4
Kyowa Kirin Co., Ltd.
Tokyo-to, Japan
Patent: 3
Prometheus Laboratories, Inc.
California, United States
Patent: 3
FYB 202 Project GmbH
Berlin, Germany
Patent: 3
Prometheus Biosciences, Inc
California, United States
Patent: 2
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 63 patents applied in the last 5 years. We discover 10 most active companies in this area. The fast-growing Janssen Biotech, Momenta Pharmaceuticals, Inc., Dong-A Socio Holdings Co., Ltd. take 87.30% of patent filing during this period.
Janssen Biotech
Belgium
Patent: 39
Momenta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 10
Dong-A Socio Holdings Co., Ltd.
South Korea
Patent: 6
Meiji Seika Pharma Co., Ltd.
Tokyo-to, Japan
Patent: 4
Kyowa Kirin Co., Ltd.
Tokyo-to, Japan
Patent: 3
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 2
University of Tokyo
Tokyo-to, Japan
Patent: 2
Prometheus Laboratories, Inc.
California, United States
Patent: 1
FYB 202 Project GmbH
Berlin, Germany
Patent: 1
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 63 patents in last 5 years, we discover 8 new entrants. Janssen Biotech, Momenta Pharmaceuticals, Inc., Dong-A Socio Holdings Co., Ltd. are the most active new entrants in this area.
Janssen Biotech
Belgium
Patent: 39
Momenta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 10
Dong-A Socio Holdings Co., Ltd.
South Korea
Patent: 6
Meiji Seika Pharma Co., Ltd.
Tokyo-to, Japan
Patent: 4
Kyowa Kirin Co., Ltd.
Tokyo-to, Japan
Patent: 3
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 2
University of Tokyo
Tokyo-to, Japan
Patent: 2
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 1 universities and scientific research institutions by total patent application.
University of Tokyo
Tokyo-to, Japan
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: